YCYong Chen

Yong Chen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yong Chen has a total of 137 co-authors. Here are the top co-authors by number of shared publications:

  • Yanjuan Chen

    Key Laboratory of Cell Engineering of Guizhou Province, Affiliated Hospital of Zunyi Medical University, Zunyi, China

    5 shared publications
  • Dongzhou Liu

    Department of Rheumatology and Immunology, Shenzhen People's Hospital (The First Affiliated Hospital, Southern University of Science and Technology; The Second Clinical Medical College, Jinan University), Shenzhen, China

    4 shared publications
  • Mei Tian

    Department of Rheumatology and Immunology, Affiliated Hospital of Zunyi Medical University, Zunyi, China

    4 shared publications
  • Anmao Li

    Department of Rheumatology and Immunology, Affiliated Hospital of Zunyi Medical University, Zunyi, China

    3 shared publications
  • Chenggen Luo

    Department of Rheumatology and Immunology, Affiliated Hospital of Zunyi Medical University, Zunyi, China

    3 shared publications
  • Kutty Selva Nandakumar

    School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China

    3 shared publications

Latest Publications

  • Open Access

    An in-depth in vitro study decodes hapln1-induced proinflammatory m1 macrophage polarization via FLSs- MΦ crosstalk: integrating bioinformatic analysis to functional study

    by Chenggen Luo, Yanjuan Chen, Kun Huang, Yunting Chen, Shidan Tian, Yulei Ao, Anmao Li, Qijiang Jiang, Xiaoli Pan, Mei Tian, et al.

    Background: Secreted by fibroblast-like synoviocytes (FLSs), hyaluronan and proteoglycan link protein 1 (HAPLN1) contributes to a pro-inflammatory reaction in rheumatoid arthritis (RA), according to our previous study. In the current study, we aim to investigate the deeper roles of HAPLN1 in the mechanisms of RA, especially its impact on macrophages (MΦ). Methods: Single-cell RNA sequencing (scRNA-seq) data from human- and mouse-derived synovium were obtained from the GEO database to characterize the features of HAPLN1 + FLSs. RA-FLSs were isolated from synovial tissues of RA patients. Gain- and loss-of-function experiments were conducted by transfection of HAPLN1 -overexpression ( HAPLN1 OE ) and small interfering RNA (si- HAPLN1 ) vectors. MΦ derived from the THP-1 cell line were co-cultured with RA-FLSs in a Transwell system or treated with recombinant HAPLN1 (rHAPLN1). MΦ viability was assessed using CCK-8 and EdU assays, while M1 polarization was evaluated via flow cytometry. mRNA expression levels were detected using RNA sequencing (RNA-seq). Inflammatory cytokine expression and pathway activation were assessed by Immunofluorescence, Western blot, and reverse transcription quantitative polymerase chain reaction (RT-qPCR). Results: ScRNA-seq analysis revealed elevated HAPLN1 expression in RA-FLSs, along with the upregulation of extracellular matrix-related genes (e.g., COMP , MMP13 ). Cell–cell interaction analysis indicated a strong interaction between HAPLN1 + FLSs and MΦ. HAPLN1 OE RA-FLSs promoted MΦ polarization toward the proinflammatory M1 phenotype under co-culture, marked by increased expression of iNOS, CD80, IL-1β, IL-6, TNF-α, and IL-8 . rHAPLN1-treated MΦ exhibited similarly enhanced viability, an increased M1 polarization ratio, and elevated proinflammatory cytokine levels. In contrast, si- HAPLN1 RA-FLSs reduced M1 polarization, but rHAPLN1 supplementation reversed this effect. RNA-seq and validation assays further suggested that rHAPLN1 facilitates MΦ polarization via PI3K/AKT/NF-κB signaling. Conclusion: This study provides the first evidence that RA-FLS-derived HAPLN1 drives M1 polarization through PI3K/AKT/NF-κB signaling, highlighting its pathogenic role in RA and its potential as a therapeutic target.

  • Open Access

    HAPLN1 Exhibits Dual Effects: Facilitating Extracellular Matrix Restoration while Enhancing Inflammatory Mediator Production in Arthritic Chondrocytes

    by Yunting Chen, Chenggen Luo, Kun Huang, Xiaoli Pan, Yulei Ao, Shidan Tian, Mang He, Anmao Li, Yanjuan Chen, Mei Tian, et al.

    Hyaluronan and proteoglycan link protein 1 (HAPLN1) secreted by fibroblast-like synoviocytes (FLSs) plays a critical role in the pathological process of inflammatory arthritis. This study aimed to investigate the impact and underlying mechanisms of HAPLN1 in an inflamed chondrocyte model. IL-1β-treated SW1353 chondrocytes were exposed to recombinant HAPLN1 (rHAPLN1). A transwell coculture system was used to assess interactions between the chondrocytes and FLSs transfected with the HAPLN1 overexpression plasmid. Cell viability and proliferation were evaluated using cell counting kit-8 (CCK-8) assay and 5-ethynyl-2'-deoxyuridine (EdU) assay. RNA sequencing and bioinformatic analyses, including the identification of differentially expressed genes (DEGs), gene functional enrichment and protein-protein interaction analyses were conducted to explore the potential mechanisms. Our fundings revealed that HAPLN also increased the levels of inflammatory mediators (TNF-α, IL-6, MMP1, MMP3, MMP9, and ADAMTS-5) in the inflamed chondrocytes, suggesting its pro-inflammatory effect. However, HAPLN1 enhanced cell viability, and the expression of Collagen II and TGF-β, the restoration effect of extracellular matrix (ECM). Bioinformatics analysis suggested the upregulated DEGs were enriched in the inflammatory processes, and the pathways related to ECM, TNF and IL-6 were activated in inflamed chondrocytes following rHAPLN1 exposure. Additionally, the protein-protein interaction networks indicated that HAPLN1 interacts with the molecules related to ECM, inflammation, and PI3K/AKT/mTOR pathway. Western blot assay further verified that the phosphorylation of PI3K, AKT, and mTOR was elevated in the rHAPLN1-treated chondrocytes. Our findings highlight the dual effects of HAPLN1 on the arthritic chondrocytes, which may be associated with the activation of the PI3K/AKT/mTOR pathway.


  • Open Access

    Interpretation of the Pathological Mechanism of Blood Stasis in Traditional Chinese Medicine in Light of Understanding of Hypercoagulable States in Modern Medicine

    by Yong Chen, Yujie Zhang

    In both Traditional Chinese Medicine (TCM) and modern medicine, they agree that the integrity and healthy structure of the vascular endothelium are essential for normal hemodynamics. Damage to the vascular endothelium can quickly activate the extrinsic coagulation pathway by triggering the tissue factor (TF) and lead to coagulation. This damage, along with a loss of anticoagulant properties through antithrombin III (AT III), TF pathway inhibitors, and the protein C system, can result in a hypercoagulable state and even thrombosis. Hypercoagulability is not only a common feature of many cancers but also an important factor promoting tumor development and metastasis, which corresponds to the TCM theory of “blood stasis leading to tumors.” The pharmacological effects of heparin and aspirin have similarities with TCM's “activating blood circulation and removing blood stasis” theory in improving blood circulation, treating related diseases, and their anti-inflammatory effects.


  • Iatrogenic Cushing's Syndrome With Lipid Deposition in Spinal Canal

    by Yong Chen, Cai‐Lin Li, Yan‐Juan Chen, Juan Chen

  • Open Access

    How Were the Elderly RA Patients Doing Over the Past Year?—A Post Hoc Analysis for Telephone Based Following Up to RA Patients in Zunyi China

    by Yong Chen, Yan-Juan Chen, Jian-Feng Luo, Mang He, Si-Jin Zhao, Shi-Dan Tian, Yong-Qiao Zhang, Xiao-Long Chen, Chuan-Jie Yang, Yu-Zhuo Luo, et al.

    Purpose: The quality of life (QoL) of elderly patients with rheumatoid arthritis (RA) in Zunyi China based on health parameters has not been previously analyzed. This study compares the 36-Item Short Form Health Survey (SF-36) scores and prevailing health complications between < 60y and ≥ 60y patients with RA. Data from 1166 patients with RA who visited the rheumatology department of Zunyi Medical University Hospital were followed up and retrospectively analyzed. Patients and Methods: Data from 1166 patients with RA who visited the rheumatology department of Zunyi Medical University Hospital (2021.1– 2022.8) were followed up and retrospectively analyzed. Results: Twenty cases passed away at 61.55 ± 8.11y, which was 6.75 years less than the local average age of death. Elderly patients with RA reported lower recovery levels, and their levels of inflammatory markers such as Immunoglobulin M-rheumatoid factor (IgM-RF), erythrocyte sedimentation rate (ESR), and C-reactive protein (CRP) levels were significantly higher than those of younger patients during their past one-year observation period. The SF-36 results indicated that eight items of QoL in the elderly patients were all significantly inferior to < 60y patients, while the complications of interstitial lung disease (ILD), latent tuberculosis infection (LTBI) and, lung and herpes zoster infections were significantly higher. Conclusion: Elderly patients had a higher disease activity along with poor QoL, more health-related complications, and susceptibility to infections. Our study emphasizes the imperative need for optimization of RA treatment modalities in the elderly to alleviate their sufferings.

  • Secretory Phenotype in Peripheral Blood Mononuclear Cells of Elderly Patients with Rheumatoid Arthritis

    by Wenlong Wang, Yanjuan Chen, Yidi Shen, Jian Chen, Xiaoyang Yao, Yongjun Cheng, Jinzhong Xu, Lisha Ma, Yong Chen, Chuanfu Zhang

    This study aims to investigate the expression differences of peripheral blood mononuclear cells (PBMCs) in patients with elderly rheumatoid arthritis (ERA). Differentially expressed genes (DEGs) of PBMCs between young patients with RA (RA_Y) and elderly patients with RA (RA_A) were identified by RNA sequencing using the DESeq2 package, followed by bioinformatics analysis. The overlapped targets of the current DEGs and proteomic differentially expressed proteins (another set of unpublished data) were identified and further validated. The bioinformatics analysis revealed significant transcriptomic heterogeneity between RA_A and RA_Y. A total of 348 upregulated and 363 downregulated DEGs were identified. Gene functional enrichment analysis indicated that the DEGs, which represented senescence phenotype for patients with ERA, were enriched in pathways such as Phosphatidylinositol3 kinase/AKT serine-threonine protein kinase (PI3K/Akt) signaling, Mitogen-activated protein kinases (MAPK) signaling, toll-like receptor family, neutrophil degranulation, and immune-related pathways. Gene set enrichment analysis further confirmed the activation of humoral immune response pathways in RA_A. Quantitative polymerase chain reaction validated the expression of five representative DEGs such as SPTA1 , SPTB , VNN1 , TNXB , and KRT1 in PBMCs of patients with ERA. Patients with ERA have significant senescence phenotype differences versus the young patients. The DEGs identified may facilitate exploring the biomarkers of senescence in RA.


  • Open Access

    Acupoint Autohemotherapy Attenuates DNCB-Induced Atopic Dermatitis and Activates Regulatory T Cells in BALB/c Mice

    by Shi-Hua Yan, Yong Chen, Zhi-Qian Huang, Wen-Xi Zhong, Xiao-Tian Wang, Yang-Can Tang, Xu-Yi Zhao, Yu-Shan Wu, Chun Zhou, Wei Zhu, et al.

    Purpose: Acupoint autohemotherapy (A-AHT) has been proposed as an alternative and complementary treatment for atopic dermatitis (AD), yet the exact role of its blood component in terms of therapeutic efficacy and mechanism of action is still largely unknown. Methods: This study aimed to evaluate the therapeutic efficacies and action mechanisms of intramuscular injections of autologous whole blood (AWB) and mouse immunoglobulin G (IgG) (autologous or heterologous) at acupoints on 2,4-dinitrochlorobenzene (DNCB)-induced AD mouse models. Serum levels of total immunoglobulin E (IgE), IgG, interleukin-10 (IL-10), and interferon-gamma (IFN-γ) were measured, as well as mRNA expression levels of Forkhead box P3 (FoxP3), IL-10 and IFN-γ in dorsal skin lesions, and IL-10+, IFN-γ+ and FoxP3+CD4+T cells in murine spleen. Results: It showed that repeated acupoint injection of AWB, autologous total IgG (purified from autologous blood in AD mice) or heterologous total IgG (purified from healthy blood in normal mice) effectively reduced the severity of AD symptoms and decreased epidermal and dermal thickness as well as mast cells in skin lesions. Additionally, AWB acupoint injection was found to upregulate FoxP3+, IL-10+ and IFN-γ+ CD4+T cells in murine spleen, suppressing the production of IgE antibodies and increasing that of IgG antibodies in the serum. Furthermore, both AWB and autologous total IgG administrations significantly elevated FoxP3 expression, mRNA levels of IL-10 and IFN-γ in dorsal skin lesions. However, acupoint injection of heterologous total IgG had no effect on regulatory T (Treg) and Th1 cells modulation. Conclusion: These findings suggest that the therapeutic effects of A-AHT on AD are mediated by IgG-induced activation of Treg cells.


  • Top Cited Papers
    Open Access

    Icariin inhibits chondrocyte ferroptosis and alleviates osteoarthritis by enhancing the SLC7A11/GPX4 signaling

    by Juan Xiao, Chenggen Luo, Anmao Li, Fanglan Cai, Yu Wang, Xiaoli Pan, Liu Xu, Zihong Wang, Zhouxiong Xing, Limei Yu, et al.


  • Open Access

    Characteristics of PD‐1+CD4+ T cells in peripheral blood and synovium of rheumatoid arthritis patients

    by Yan‐Juan Chen, Yong Chen, Ping Chen, Yi‐Qun Jia, Hua Wang, Xiao‐Ping Hong

    Objectives: PD‐1 plays a crucial role in the immune dysregulation of rheumatoid arthritis (RA), but the specific characteristics of PD‐1+CD4+ T cells remain unclear and require further investigation.Methods: Circulating PD‐1+CD4+ T cells from RA patients were analysed using flow cytometry. Plasma levels of soluble PD‐1 (sPD‐1) were measured using enzyme‐linked immunosorbent assay (ELISA). Single‐cell RNA sequence data from peripheral blood mononuclear cells (PBMCs) and synovial tissue of patients were obtained from the GEO and the ImmPort databases. Bioinformatics analyses were performed in the R studio to characterise PD‐1+CD4+ T cells. Expression of CCR7, KLF2 and IL32 in PD‐1+CD4+ T cells was validated by flow cytometry.Results: RA patients showed an elevated proportion of PD‐1+CD4+ T cells in peripheral blood, along with increased plasma sPD‐1 levels, which positively correlated with TNF‐α and erythrocyte sedimentation rate. Bioinformatic analysis revealed PD‐1 expression on CCR7+CD4+ T cells in PBMCs, and on both CCR7+CD4+ T cells and CXCL13+CD4+ T cells in RA synovium. PD‐1 was co‐expressed with CCR7, KLF2, and IL32 in peripheral CD4+ T cells. In synovium, PD‐1+CCR7+CD4+ T cells had higher expression of TNF and LCP2, while PD‐1+CXCL13+CD4+ T cells showed elevated levels of ARID5A and DUSP2. PD‐1+CD4+ T cells in synovium also appeared to interact with B cells and fibroblasts through BTLA and TNFSF signalling pathways.Conclusion: This study highlights the increased proportion of PD‐1+CD4+ T cells and elevated sPD‐1 levels in RA. The transcriptomic profiles and signalling networks of PD‐1+CD4+ T cells offer new insights into their role in RA pathogenesis.